Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
Gupse AdaliPinar GokcenFatih GuzelbulutAyca Gokcen Degirmenci SalturkNihat Buğra AğaoğluBusra UnalHamdi Levent DoganayKamil ÖzdilPublished in: Hepatology forum (2021)
HBV infection was not associated with mortality in patients with COVID-19, and it seems that NUC treatment for HBV infection might have an antiviral effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.